- Home
- REE vs CRIS Comparison
REE vs CRIS Comparison
Compare REE & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | REE | CRIS |
|---|---|---|
| Founded | 2011 | 2000 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.1M | 14.0M |
| IPO Year | 2021 | 2000 |
Fundamental Metrics
Financial Performance| Metric | REE | CRIS |
|---|---|---|
| Price | $0.61 | $0.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $8.50 | ★ $17.00 |
| AVG Volume (30 Days) | 30.2K | ★ 663.6K |
| Earning Date | 05-14-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 91.57 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $9,898,000.00 |
| Revenue This Year | $327.73 | $27.10 |
| Revenue Next Year | $36,888.82 | $67.74 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 31.50 |
| 52 Week Low | $0.51 | $0.49 |
| 52 Week High | $3.25 | $3.13 |
Technical Indicators
Market Signals| Indicator | REE | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 50.33 | 41.98 |
| Support Level | $0.53 | N/A |
| Resistance Level | $0.74 | $1.04 |
| Average True Range (ATR) | 0.06 | 0.08 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 54.15 | 37.69 |
Price Performance
Historical ComparisonAbout REE REE Automotive Ltd.
REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is in early stages of commercialization and develop and produce software-defined vehicle (SDV) technology that manages vehicle operations and features through proprietarily-developed software. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.